Patient-centric ePRO strengthens retention and compliance in a Phase III bladder cancer trial

Amber Burg

Amber Burg is the Therapeutic Area Delivery Head for Neuroscience and Ophthalmology at Fortrea, based in the US.

David Brock

David Brock, Senior Director for Strategic Delivery and Growth, is based in the UK and has over 35 years of experience in clinical research.

Addressing the implications for long-term follow-up in discontinued gene therapy studies

Fortrea Adjudication: Your Trusted Partner for Oversight Committee Management

Transforming Oncology Clinical Research: A Decade of Partnership with Fortrea FSP

Building trust in a Functional Service Provider (FSP) relationship starts with a collaborative relationship and the ability to respond with agility to evolving needs.

Transforming a Long-Term FSP partnership to enhance global oncology studies

Intensive Bioresearch Monitoring (BIMO) preparation is key to successful inspection results for sponsors and sites